Cyclobutylcarbamic Acid Benzyl Ester

Cyclobutylcarbamic Acid Benzyl Ester

SCHEMBL579215

O=C(NC1CCC1)OCc1ccccc1.O=C(O)O

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Cyclobutylcarbamic Acid Benzyl Ester. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.74
ALDH1A1 P00352 3/20 0.74
GAA P10253 1/20 0.74
TSHR P16473 1/20 0.70
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
DPP4 P27487 3/20 0.59
DPP7 Q9UHL4 3/20 0.59
KCNH2 Q12809 1/20 0.59
CTSL P07711 1/20 0.59
CTSB P07858 1/20 0.59
CTSK P43235 1/20 0.59
TLR4 O00206 1/20 0.54
EPHX2 P34913 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclobutylcarbamic Acid Benzyl Ester SCHEMBL332814 0.98 EPHX1 (0.76) EPHX1ALDH1A1GAATSHRMEN1
Bicarbonate SCHEMBL6203780 0.95 EPHX1 (0.82) EPHX1ALDH1A1GAATSHRMEN1
SCHEMBL7198149 0.95 EPHX1 (0.81) EPHX1ALDH1A1GAATSHRMEN1
SCHEMBL1424064 0.94 EPHX1 (0.84) EPHX1ALDH1A1GAATSHRMEN1
SCHEMBL8393719 0.94 EPHX1 (0.84) EPHX1ALDH1A1GAATSHRMEN1
Cyclobutylcarbamic Acid Benzyl Ester SCHEMBL27741202 0.93 EPHX1 (0.69) EPHX1ALDH1A1GAATSHRMEN1
Cyclobutylcarbamic Acid Benzyl Ester SCHEMBL29047875 0.93 EPHX1 (0.73) EPHX1ALDH1A1GAATSHRMEN1
SCHEMBL328941 0.93 EPHX1 (0.69) EPHX1ALDH1A1GAATSHRMEN1
SCHEMBL5442663 0.92 EPHX1 (0.68) EPHX1ALDH1A1GAATSHRMEN1
SCHEMBL5442669 0.92 EPHX1 (0.68) EPHX1ALDH1A1GAATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027107-B1 2, 4 -DIAMINO PYRIMIDINES AS CELL CYCLE KINASE INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2012-02-15 EP disclosed
EP-2357181-A1 2,4-Diaminopyrimidines as inhibitors of cell cycle kinases Boehringer Ingelheim International GmbH (DE) 2011-08-17 EP disclosed
EP-2027107-A1 2, 4 -DIAMINO PYRIMIDINES AS CELL CYCLE KINASE INHIBITORS Boehringer Ingelheim International GmbH (DE) 2009-02-25 EP disclosed
WO-2007132010-A1 2, 4 -DIAMINO PYRIMIDINES AS CELL CYCLE KINASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-22 WO disclosed